SCNI Scinai Immunotherapeutics Ltd.
Price Chart
Executive Summary
Scinai Immunotherapeutics' shelf registration on Form F-3 (File No. 333-295698) was declared effective by the SEC on May 19, 2026. This allows the company to offer and sell securities (equity, debt, or other instruments) from time to time at its discretion. For a micro-cap biotech with a $2M market cap, this creates a tangible dilution overhang and signals potential near-term capital-raising activity.
Actionable Insight
Short-term bearish pressure expected on dilution fears typical of a post-effective micro-cap shelf. Traders should monitor for an 8-K or prospectus supplement (pricing announcement) — especially since the cross-filing actuarial data marks this effect-ipo-context + effect-shelf-context combo as an amplifier, suggesting heightened propensity to tap the shelf quickly. If the company draws the shelf at a large discount to market, expect 20-40% downside. Conversely, if no offering occurs within 30 days, bearish overhang may partially fade.
Key Facts
- Effectiveness date: May 19, 2026
- Form F-3 shelf registration (File No. 333-295698) covering unspecified securities
- Company market cap is approximately $2M; minimal absolute dollar offering could cause significant dilution
- Company has no disclosed revenue or pipeline revenue milestones in this filing
- Historical calibration data shows a net average alpha of -2.39% at T+20 for similar filing-report segment
Financial Impact
Potential dilutive offering; exact size undisclosed but at $2M market cap, even a small $500K-$1M raise could dilute existing shareholders by 20-50%
Risk Factors
- Immediate dilution risk if shelf is drawn down quickly
- Micro-cap biotech with no disclosed revenue may face severe adverse selection in equity markets
- Cross-filing amplifier verdict suggests historically elevated odds of near-term capital raise after shelf effectiveness
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001706 |
| Document: 9999999995-26-001706-index.html | 9999999995-26-001706 |
| Document: 9999999995-26-001706.txt | 9999999995-26-001706 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
4d ago
|
6-K
| $0.4111 awaiting T+5 | awaiting T+5 | — | $0.3310 (−19.48%) |
|
May 20, 2026
24d ago
|
EFFECT
| $0.4780 $0.4490 | ▲ +6.07% | ▲ +7.87% | $0.3310 (+30.75%) |
|
May 8, 2026
5w ago
|
6-K
| $0.5680 $0.5350 | ▲ +5.81% | ▲ +7.27% | $0.3310 (+41.73%) |
|
Apr 27, 2026
6w ago
|
6-K
| $0.5840 $0.6450 | ▼ −10.45% | ▼ −8.75% | $0.3310 (+43.32%) |
|
Apr 1, 2026
10w ago
|
20-F
| $0.6390 $0.5900 | ▲ +7.67% | ▲ +11.43% | $0.3310 (+48.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access